RHI Magnesita Intrinsic Value
RHI Magnesita intrinsic value. RHI Magnesita (RHIM) median intrinsic value is ₹931.88 from 4 valuation models (range ₹112–₹932), vs current price ₹372.75 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Compare with RHIM fair price to assess whether the stock is under or overvalued.
RHIM Valuation Methods Summary — DCF, Graham Number & P/E
RHI Magnesita intrinsic value across 4 models vs current price ₹372.75 — upside/downside and value range per method. For current market price and key ratios, visit RHIM screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹931.88 | ₹838.69 - ₹1025.07 | +150.0% | Book Value/Share: ₹1695.24, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹745.50 | ₹670.95 - ₹820.05 | +100.0% | Revenue/Share: ₹1822.86, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹931.88 | ₹745.50 - ₹1118.26 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| Dividend Yield Method | dividend | ₹111.83 | ₹100.65 - ₹123.01 | -70.0% | DPS: ₹2.50, Target Yield: 3.5% |
RHIM Intrinsic Value vs Market Price — All Valuation Models
RHI Magnesita fair value range ₹112–₹932 vs current market price ₹372.75 across 4 valuation models. Read RHIM dividend payout details for the complete payout history and dividend yield track record.
RHIM Intrinsic Value Analysis — Undervalued or Overvalued?
RHI Magnesita median intrinsic value ₹931.88, current price ₹372.75 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of RHIM?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of RHI Magnesita (RHIM) is ₹931.88 (median value). With the current market price of ₹372.75, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹111.83 to ₹931.88, indicating ₹111.83 - ₹931.88.
Is RHIM undervalued or overvalued?
Based on our multi-method analysis, RHI Magnesita (RHIM) appears to be trading below calculated value by approximately 150.0%.
RHIM Financial Health — Key Ratios vs Industry Benchmarks
RHI Magnesita financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.17 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -58.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -50.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.79x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
RHIM Cash Flow Quality — Operating & Free Cash Flow
RHI Magnesita operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹409 Cr | ₹240 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹373 Cr | ₹317 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹271 Cr | ₹115 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹238 Cr | ₹-337 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹27 Cr | ₹-8 Cr | Positive Operating Cash Flow | 6/10 |